AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2018
May 29, 2018
32870_dirs_2018-05-29_b3245110-bafc-4286-890c-418c461a1aba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-05-24
Reporting Person: Zoon Kathryn C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-24 | Common Stock | S | 1377 | $51.15 | Disposed | 23261 | Direct |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon.
More from Emergent BioSolutions Inc.
Earnings Release
2026
Apr 30
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Mar 3